Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 14 items for :

  • "Local treatments" x
Clear All
Laura Fugazzola Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Laura Fugazzola in
Google Scholar
PubMed Close
,
Rossella Elisei Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close
,
Dagmar Fuhrer Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany

Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed Close
,
Barbara Jarzab Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Barbara Jarzab in
Google Scholar
PubMed Close
,
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Kate Newbold Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed Close
, and
Jan Smit Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Jan Smit in
Google Scholar
PubMed Close

that continuation of RAI treatment in this situation is not beneficial. A combination of RAI therapy for RAI-avid lesions and local treatment for one or a limited number of RAI refractory lesions may be considered in certain patients. Progression

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000502229
Volume/Issue:
Volume 8: Issue 5
Free access
M. Schlumberger Department of Nuclear Medicine and Endocrine Oncology, Institute Gustave-Roussy and University Paris Sud, Villejuif, France

Search for other papers by M. Schlumberger in
Google Scholar
PubMed Close
,
L. Bastholt Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by L. Bastholt in
Google Scholar
PubMed Close
,
H. Dralle Department of Surgery, Martin Luther University, Halle-Wittenberg Medical Faculty, Halle/Saale, Germany

Search for other papers by H. Dralle in
Google Scholar
PubMed Close
,
B. Jarzab MSC Memorial Cancer Center and Institute of Oncology, Gliwice, Poland

Search for other papers by B. Jarzab in
Google Scholar
PubMed Close
,
F. Pacini Department of Endocrinologia, University of Siena, Siena, Italy

Search for other papers by F. Pacini in
Google Scholar
PubMed Close
, and
J.W.A. Smit Department of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by J.W.A. Smit in
Google Scholar
PubMed Close

for months or even years, but diarrhea may be debilitating. Slow tumor growth is common, and distant metastases limited to a single organ may be considered for curative surgical resection or another local treatment modality. Patients with distant

Article Type:
Guideline
DOI:
https://doi.org/10.1159/000336977
Volume/Issue:
Volume 1: Issue 1
Free access
Furio Pacini Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy

Search for other papers by Furio Pacini in
Google Scholar
PubMed Close

surgical complications with the evidence that a second operation rarely results in permanent cure of the neck. Local treatment options are very attractive. Good results have been reported with ethanol injection, but the above-mentioned new techniques seem

Article Type:
Editorial
DOI:
https://doi.org/10.1159/000354744
Volume/Issue:
Volume 2: Issue 3
Free access
Daniela Cavaco Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Daniela Cavaco in
Google Scholar
PubMed Close
,
Sara Carvalhal Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Sara Carvalhal in
Google Scholar
PubMed Close
, and
Valeriano Leite Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed Close

skull (Fig. 1 a, b). Fine-needle aspiration of the scalp lesions revealed PTC metastases, and thyroglobulin was >30.000 ng/mL in needle washout fluid. Later on, the lesions developed active bleeding and did not respond to local treatment with silver

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000507888
Volume/Issue:
Volume 9: Issue 4
Free access
Bjarke Borregaard Medici Department of Endocrinology, Herlev University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed Close
,
Jeppe Lerche la Cour Department of Endocrinology, Herlev University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed Close
,
Luba Freja Michaelsson Department of Endocrinology, Herlev University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed Close
,
Jens Oscar Faber Department of Endocrinology, Herlev University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Oscar Faber in
Google Scholar
PubMed Close
, and
Birte Nygaard Department of Endocrinology, Herlev University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Birte Nygaard in
Google Scholar
PubMed Close

local treatment guidelines corresponds to the ETA guidelines [ 2 ], i.e., combination treatment of L-T 4 and L-T 3 is given corresponding to a 17/1 ratio (weight/weight), and L-T 3 is given twice daily, in the morning and at bedtime, using 5-µg L-T 3

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000454878
Volume/Issue:
Volume 6: Issue 2
Free access
Luigi Bartalena University of Insubria, Varese, Italy

Search for other papers by Luigi Bartalena in
Google Scholar
PubMed Close

(DON) and/or exophthalmos-related corneal breakdown, requiring prompt treatment with very high doses of i.v. glucocorticoids (ivGCs), local treatments, and/or orbital decompression surgery ( 5 ). True challenges and therapeutic dilemmas are posed by

Article Type:
Article Commentary
Collections:
Thyroid autoimmunity
DOI:
https://doi.org/10.1530/ETJ-22-0185
Volume/Issue:
Volume 11: Issue 6
Open access
Elisa Minaldi Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Elisa Minaldi in
Google Scholar
PubMed Close
,
Virginia Cappagli Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Virginia Cappagli in
Google Scholar
PubMed Close
,
Loredana Lorusso Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Loredana Lorusso in
Google Scholar
PubMed Close
,
Laura Valerio Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Laura Valerio in
Google Scholar
PubMed Close
,
Carlotta Giani Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Carlotta Giani in
Google Scholar
PubMed Close
,
Matilde Viglione Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Matilde Viglione in
Google Scholar
PubMed Close
,
Laura Agate Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Laura Agate in
Google Scholar
PubMed Close
,
Eleonora Molinaro Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed Close
,
Antonio Matrone Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Antonio Matrone in
Google Scholar
PubMed Close
, and
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Via Paradisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close

M1 stage in 34/74 patients (45.9%). Regarding previous TC treatments, 49/74 (66.2%) received 131-I treatments before starting sorafenib, while 33/74 (44.6%) were submitted to other single systemic (chemotherapy, other MKI) or local treatments (i

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-24-0009
Volume/Issue:
Volume 13: Issue 4
Open access
Hélène Théodon Department of Thyroid and Endocrine Tumors, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Hélène Théodon in
Google Scholar
PubMed Close
,
Erell Guillerm Department of Oncogenetic, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Erell Guillerm in
Google Scholar
PubMed Close
,
Johanna Wassermann Department of Oncology, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Johanna Wassermann in
Google Scholar
PubMed Close
,
Gabrielle Deniziaut Department of Pathology, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed Close
,
Loïc Jaffrelot Department of Oncology, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Loïc Jaffrelot in
Google Scholar
PubMed Close
,
Jérome Denis Department of Endocrine and Oncology Biochemistry, Sorbonne Université, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Jérome Denis in
Google Scholar
PubMed Close
,
Nathalie Chereau Department of Endocrine Surgery, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Nathalie Chereau in
Google Scholar
PubMed Close
,
Claude Bigorgne Department of Pathology, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Claude Bigorgne in
Google Scholar
PubMed Close
,
Wiame Potonnier Department of Pathology, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Wiame Potonnier in
Google Scholar
PubMed Close
,
Florence Coulet Department of Oncogenetic, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Florence Coulet in
Google Scholar
PubMed Close
,
Laurence Leenhardt Department of Thyroid and Endocrine Tumors, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed Close
, and
Camille Buffet Department of Thyroid and Endocrine Tumors, Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close

procedures with intrinsic risks and extended waiting times for molecular results. Such procedures seem even less safe when local treatment of the distant metastatic location is not planned and systemic therapy is warranted. Molecular testing on the fine

Article Type:
Research Article
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-23-0164
Volume/Issue:
Volume 13: Issue 1
Open access
Maria Mavromati Department of Endocrinology, Diabetology, Nutrition and Therapeutic Education, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva University, Geneva, Switzerland

Search for other papers by Maria Mavromati in
Google Scholar
PubMed Close
,
Essia Saiji Department of Pathology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Essia Saiji in
Google Scholar
PubMed Close
,
Marco Stefano Demarchi Department of Endocrine Surgery, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed Close
,
Vincent Lenoir Department of Radiology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Vincent Lenoir in
Google Scholar
PubMed Close
,
Amanda Seipel Department of Pathology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Amanda Seipel in
Google Scholar
PubMed Close
,
Paulina Kuczma Department of Endocrine Surgery, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Paulina Kuczma in
Google Scholar
PubMed Close
,
François R Jornayvaz Department of Endocrinology, Diabetology, Nutrition and Therapeutic Education, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva University, Geneva, Switzerland

Search for other papers by François R Jornayvaz in
Google Scholar
PubMed Close
,
Minerva Becker Department of Radiology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Minerva Becker in
Google Scholar
PubMed Close
,
Eugenio Fernandez Department of Oncology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed Close
,
Claudio De Vito Department of Pathology, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Claudio De Vito in
Google Scholar
PubMed Close
,
Frédéric Triponez Department of Endocrine Surgery, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva, Switzerland

Search for other papers by Frédéric Triponez in
Google Scholar
PubMed Close
, and
Sophie Leboulleux Department of Endocrinology, Diabetology, Nutrition and Therapeutic Education, Geneva University Hospitals, Rue Gabrielle Perret Gentil, Geneva University, Geneva, Switzerland

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close

with surgery, active surveillance, or local treatment, depending on the size of the nodule ( 3 , 4 , 5 , 6 ). Given the high rate of thyroid nodules, most of which are benign, to reduce fine needle aspiration cytology (FNAC) and unnecessary surgery

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-23-0114
Volume/Issue:
Volume 12: Issue 6
Open access
Mats Holmberg ANOVA, Karolinska University Hospital, Norra Stationsgatan 69, Stockholm, Sweden
Institute of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden

Search for other papers by Mats Holmberg in
Google Scholar
PubMed Close
,
Helge Malmgren Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Helge Malmgren in
Google Scholar
PubMed Close
,
Peter F Berglund Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Peter F Berglund in
Google Scholar
PubMed Close
,
Birgitta Johansson Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed Close
, and
Helena Filipsson Nyström Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Gothenburg Centre for Person Centred-Care (GPCC), Göteborg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed Close

with the local treatment scheme for premenopausal female adult patients with GD where all patients received either antithyroid drugs (ATD) or surgery with previous ATD treatment. As an exception, one patient was treated with radioactive iodine

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0247
Volume/Issue:
Volume 13: Issue 1
Open access